Literature DB >> 25323995

Long-Term Follow-Up after Surgery for Congenital and Developmental Cataracts.

Adriano Magli1,2, Raimondo Forte1,3, Roberta Carelli1, Giulia Magli2, Francesca Esposito2, Angelo Torre2.   

Abstract

PURPOSE: To evaluate long-term functional outcomes after surgery for congenital and developmental cataracts.
METHODS: In this retrospective interventional study, patients with congenital and developmental cataracts observed from 1996 to 2013 were included. Traumatic cataracts and cataracts secondary to other pathologies were excluded from the study. Minimum follow-up for inclusion was five years.
RESULTS: We included 117 patients operated on for congenital cataracts (58 females and 59 males, mean age 0.59 ± 0.2 years, 160 eyes) and 73 patients operated on for developmental cataracts (32 females and 41 males, mean age 6.63 ± 0.7 years, 121 eyes). Mean postsurgical follow-up was 9.26 ± 1.3 years (range, 5-14 years). After surgery for developmental cataracts, both distance and near BCVA were greater (p = 0.001), as was the presence of binocular vision (p = 0.001), while incidence of strabismus and myopic shift was lower (p = 0.001 and p = 0.02, respectively).
CONCLUSION: Postsurgical data showed better functional outcomes in developmental cataracts when compared to congenital cataracts.

Entities:  

Keywords:  Binocular vision; intraocular lens; myopic shift; strabismus; visual acuity

Mesh:

Year:  2014        PMID: 25323995     DOI: 10.3109/08820538.2014.962160

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  2 in total

1.  Comparison between two devices in the detection of corneal thickness changes after cataract surgery.

Authors:  Maddalena De Bernardo; Livio Vitiello; Giulia Abbinante; Ilaria De Pascale; Luigi Capasso; Giuseppe Marotta; Nicola Rosa
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

2.  Pediatric traumatic cataracts: 10-year experience of a tertiary referral center.

Authors:  Nesrin Tutaş Günaydın; Ayşe Yeşim Aydın Oral
Journal:  BMC Ophthalmol       Date:  2022-05-02       Impact factor: 2.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.